<p>A. The levels of RBP2 protein in the A549 cells separately treated with different siRNAs. B. Immunofluorescence analysis of RBP2 in untreated A549 cells and cells treated with RBP2 siRNA2 (magnification × 200).</p
<p>RPE-J cells were transfected with a pool of Grb2 targeting siRNAs or a non-targeting siRNA contro...
<p>(A) RNA and protein expression of Tβ4 in control siRNA-, Tβ4 siRNA- or non-treated LX-2 cells. Da...
<p>Cells were pretreated with 20 µmol/L of Rb1, treated with or without 60 µmol/L of H<sub>2</sub>O<...
<p>(A, C) RBP2 expression was measured by western blotting. (B, D) Flow cytometry analysis of the ef...
<p>(A) qRT-PCR analysis of RBP2 and BCL2 mRNA levels after transfection with RBP2-siRNA in Jurkat ce...
<p>(A, B) Flow cytometry analysis of apoptotic cells induced by 2 μM ABT-199 with or without RBP2-si...
<p>(A) The protein levels of single DNA2- or CtIP-depleted cells and double DNA2/CtIP-depleted cells...
<p>(A) Representative immunostaining of RBP2 overexpressed in normal and cancer tissue. (B) Quantifi...
<p>(A) qRT-PCR analysis of Hsa-miR-212 mRNA expression in cancer cells with hsa-miR-212 overexpressi...
<p>Tube formation assay: (A) control-siRNA H1975 cells; (B) RBP2-siRNA1 H1975 cells; (C) RBP2-siRNA2...
<p>(A) Anti-NRF2 Western Blot of tissue cell lysates after siRNA to the indicated screening hits. Tr...
<p>(A) Predicted binding sites of RBP2 in the BCL2 promoter (-1078~-1620) were divided into regions ...
(A) Immunoblot validation of LC-MS/MS data showing phosphorylation of Rb residues S249, S612, S807, ...
<p>(A) RBP2 is overexpressed in human NSCLC cell lines SK-MES-1, A549, SPCA-1 and H1975 compared to ...
<p>(a) RBE cells were transiently transfected with siRNAs (RBE-siIRS2, RBE-siCUL4A and RBE-siTFDP1)....
<p>RPE-J cells were transfected with a pool of Grb2 targeting siRNAs or a non-targeting siRNA contro...
<p>(A) RNA and protein expression of Tβ4 in control siRNA-, Tβ4 siRNA- or non-treated LX-2 cells. Da...
<p>Cells were pretreated with 20 µmol/L of Rb1, treated with or without 60 µmol/L of H<sub>2</sub>O<...
<p>(A, C) RBP2 expression was measured by western blotting. (B, D) Flow cytometry analysis of the ef...
<p>(A) qRT-PCR analysis of RBP2 and BCL2 mRNA levels after transfection with RBP2-siRNA in Jurkat ce...
<p>(A, B) Flow cytometry analysis of apoptotic cells induced by 2 μM ABT-199 with or without RBP2-si...
<p>(A) The protein levels of single DNA2- or CtIP-depleted cells and double DNA2/CtIP-depleted cells...
<p>(A) Representative immunostaining of RBP2 overexpressed in normal and cancer tissue. (B) Quantifi...
<p>(A) qRT-PCR analysis of Hsa-miR-212 mRNA expression in cancer cells with hsa-miR-212 overexpressi...
<p>Tube formation assay: (A) control-siRNA H1975 cells; (B) RBP2-siRNA1 H1975 cells; (C) RBP2-siRNA2...
<p>(A) Anti-NRF2 Western Blot of tissue cell lysates after siRNA to the indicated screening hits. Tr...
<p>(A) Predicted binding sites of RBP2 in the BCL2 promoter (-1078~-1620) were divided into regions ...
(A) Immunoblot validation of LC-MS/MS data showing phosphorylation of Rb residues S249, S612, S807, ...
<p>(A) RBP2 is overexpressed in human NSCLC cell lines SK-MES-1, A549, SPCA-1 and H1975 compared to ...
<p>(a) RBE cells were transiently transfected with siRNAs (RBE-siIRS2, RBE-siCUL4A and RBE-siTFDP1)....
<p>RPE-J cells were transfected with a pool of Grb2 targeting siRNAs or a non-targeting siRNA contro...
<p>(A) RNA and protein expression of Tβ4 in control siRNA-, Tβ4 siRNA- or non-treated LX-2 cells. Da...
<p>Cells were pretreated with 20 µmol/L of Rb1, treated with or without 60 µmol/L of H<sub>2</sub>O<...
DOI
Add to ORKG